Loading clinical trials...
Loading clinical trials...
Immediate Effects of STENDO on the Walking Abilities of Patients with COPD
The STENDO process is a heart rate synchronized massage system initially validated for the treatment of lymphedema. It is a combination enveloping the lower limbs up to the abdomen. The massage system induces pressure from the ankles to the abdomen between each heartbeat. This technique would also allow an improvement of endothelial function by a greater release of nitric oxide. Thus the capacity for physical exercise is potentially improved. The use of STENDO has never been evaluated in COPD (Chronic obstructive pulmonary disease) where physical capacity is impaired with, in particular, the presence of endothelial dysfunction. STENDO may improve walking performance. If these hypotheses are validated, the STENDO could be positioned as a complement to the exercise rehabilitation strategies offered to symptomatic COPD patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Polyclinique de l'Ormeau
Tarbes, France
Start Date
January 4, 2023
Primary Completion Date
May 27, 2024
Completion Date
May 27, 2024
Last Updated
September 5, 2024
32
ACTUAL participants
STENDO session
DEVICE
A six-minute walking distance test
OTHER
Near Infrared Spectroscopy
OTHER
STENDO placebo
DEVICE
Lead Sponsor
Elsan
Collaborators
NCT07477600
NCT07462221
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions